News
Haleon, maker of Sensodyne, has partnered with the Egyptian Dental Association and FDI World Dental Federation to launch the ...
British consumer healthcare group Haleon on Tuesday said it gained full control of its Chinese joint venture after acquiring ...
The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines, the latest effort by ...
Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...
Haleon PLC closed 7.49% short of its 52-week high of £4.18, which the company achieved on March 4th.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Employing around 760 people at its Dungarvan base, Haleon, formerly GSK, has had a long and deep-rooted connection with ...
Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...
Haleon has officially launched Centrum across Pakistan, marking a significant milestone as the world’s No.1 multivitamin ...
Canada Soccer and Haleon Canada announced a new multi-year partnership committed to promoting health and wellness on and off ...
Complete Haleon PLC ADR stock information by Barron's. View real-time HLN1N stock price and news, along with industry-best analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results